The efficacy and safety of crizotinib in the treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer: a meta-analysis of clinical trials
Crossref DOI link: https://doi.org/10.1186/1471-2407-14-683
Published Online: 2014-09-19
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Qian, Haili
Gao, Feng
Wang, Haijuan
Ma, Fei
License valid from 2014-09-19
Article History
Received: 25 April 2014
Accepted: 9 September 2014
First Online: 19 September 2014